Article in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Jeanne S MandelblattGeorgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Washington, DC.
Candace MainorLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University and MedStar Health, MedStar-Georgetown University Hospital, Washington, DC.
Barry I HudsonLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Georgetown University, Washington, DC.
Funding
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINER01CA129769 · NCI · GEORGETOWN UNIVERSITY · PI AHLES, TIM ALAN, MANDELBLATT, JEANNE · 2009 to 2020
$7.3M
Bio-behavioral Research At The Intersection of Cancer and AgingR35CA197289 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2015 to 2021
$6.2M
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and AgingR35CA283926 · NCI · GEORGETOWN UNIVERSITY · PI Jeanne Mandelblatt · 2023 to 2026
$3.7M
Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related DementiasR01AG082348 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith E Carroll, Jeanne Mandelblatt · 2023 to 2026
$3.3M
I-REACH (Infrastructure for REsearch on Cancer and Aging)R33AG075008 · NIA · GEORGETOWN UNIVERSITY · PI Lucile L. Adams-Campbell, Judith E Carroll · 2024 to 2026
$2.3M
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancerR01CA276587 · NCI · GEORGETOWN UNIVERSITY · PI Barry Ian Hudson, JOYCE MARIE SLINGERLAND · 2023 to 2026
$2.1M
Heterogeneity in biological, physical, and cognitive aging in older breast cancer survivors and controlsR56AG068086 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARROLL, JUDITH E, MANDELBLATT, JEANNE · 2021 to 2021
$886k
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and HealthR21AG075008 · NIA · GEORGETOWN UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE LAUREN, CARROLL, JUDITH E · 2022 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity. · full record | OpenQuestion